ロード中...
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents
Plasma cell leukemia (PCL) is a rare hematologic malignancy with aggressive clinical and biologic features. Data regarding its prognosis with the use of the novel agents, i.e., the immunomodulatory drugs thalidomide and lenalidomide, and the proteasome inhibitor bortezomib, are limited. We retrospec...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3475946/ https://ncbi.nlm.nih.gov/pubmed/23087795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2012.e39 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|